Back to Journals » Journal of Hepatocellular Carcinoma
ISSN: 2253-5969
- View all (792)
- Volume 12, 2025 (87)
- Volume 11, 2024 (181)
- Volume 10, 2023 (176)
- Volume 9, 2022 (101)
- Volume 8, 2021 (120)
- Volume 7, 2020 (37)
- Volume 6, 2019 (16)
- Volume 5, 2018 (14)
- Volume 4, 2017 (16)
- Volume 3, 2016 (10)
- Volume 2, 2015 (17)
- Volume 1 , 2014 (17)
Journal Articles:
- 792 records -
Treatment Outcomes of Systemic Therapies for Infiltrative Hepatocellular Carcinoma
Chen PY, Chang CK, Chen BB, Hsu CH, Cheng AL, Shao YY
Journal of Hepatocellular Carcinoma 2025, 12:1221-1229
Published Date: 23 June 2025

Application of Robotic Surgery in Hepatocellular Carcinoma
Li PH, Ding ZW, Ye YQ
Journal of Hepatocellular Carcinoma 2025, 12:1217-1220
Published Date: 19 June 2025
Hepatic Arterial Infusion Chemotherapy Combined Apatinib/Camrelizumab for Recurrent Hepatocellular Carcinoma After Hepatectomy
Zheng X, Qian K
Journal of Hepatocellular Carcinoma 2025, 12:1205-1215
Published Date: 17 June 2025
In Situ Vaccination with Poly-ICLC Combined with Systemic Nivolumab for the Treatment of Unresectable Hepatocellular Carcinoma
Liang JD, Liang PC, Shun CT, Chen CH, Wu YM, Hsu YC, Lee YT, Yang PM, Huang GT, Salazar AM, Lee HS, Sheu JC, Weng MT
Journal of Hepatocellular Carcinoma 2025, 12:1191-1204
Published Date: 14 June 2025
Intravoxel Incoherent Motion Improves the Accuracy of Preoperative Prediction of Vessels Encapsulating Tumor Clusters in Hepatocellular Carcinoma
Li M, Zhang G, Li J, Ren Y, Jin X, Ke Q, Guo C, Lv J, Lu H, Xu Y, Liang W, Quan X, Li X
Journal of Hepatocellular Carcinoma 2025, 12:1177-1190
Published Date: 11 June 2025
Early Recurrence of Hepatocellular Carcinoma in Patients without Microscopic Vascular Invasion: Clinicopathological Characteristics and Risk Factors
Ngo HTT, Nguyen DD, Dang MX, Doan TTP, Thai TT
Journal of Hepatocellular Carcinoma 2025, 12:1167-1175
Published Date: 11 June 2025
Genetic Variants of UGP2 and FBP2 in the Glycolysis Pathway Independently Predict Survival of Patients with HBV-Related Hepatocellular Carcinoma
Gong R, Qiu M, Liu Y, Cao J, Zhou Z, Lin Q, Jiang Y, Liang X, Wei Y, Wen Q, Chen P, Wei X, Wei J, Zhan S, Zhang R, Ye D, Yu H
Journal of Hepatocellular Carcinoma 2025, 12:1155-1166
Published Date: 7 June 2025
Factor Analysis of the Effect of Hepatitis B-Related Liver Cancer Treatment Efficacy
Liu SW, Zhou Y, Feng XY, Hai L, Ma WL, Ma LN, Ding XC, Luo X
Journal of Hepatocellular Carcinoma 2025, 12:1141-1154
Published Date: 5 June 2025
Radiomics and Deep Learning as Important Techniques of Artificial Intelligence — Diagnosing Perspectives in Cytokeratin 19 Positive Hepatocellular Carcinoma
Wang F, Yan C, Huang X, He J, Yang M, Xian D
Journal of Hepatocellular Carcinoma 2025, 12:1129-1140
Published Date: 5 June 2025
Predicting Resistance and Survival of HCC Patients Post-HAIC: Based on Shapley Additive exPlanations and Machine Learning
Yao F, Miao J, Quan B, Li J, Tang B, Lu S, Yin X
Journal of Hepatocellular Carcinoma 2025, 12:1111-1128
Published Date: 31 May 2025

Effectiveness and Safety of Systemic Therapy and Stereotactic Body Radiotherapy in Oligoprogressive and Oligometastatic Hepatocellular Carcinoma


Song Z, Zheng X, Wang H, Dong D, Zhu X, Geng J, Li S, Song M, Du R, Zhang Y, Liu Z, Cai Y, Li Y, Wang W
Journal of Hepatocellular Carcinoma 2025, 12:1097-1110
Published Date: 31 May 2025
Intratumoral and Peritumoral Radiomics Based on DCE-MRI for Prediction of Microvascular Invasion Grading in Solitary Hepatocellular Carcinoma (≤3 cm)
Li Y, Li H, Feng Y, Lu L, Zhang J, Jia N
Journal of Hepatocellular Carcinoma 2025, 12:1083-1095
Published Date: 30 May 2025
Spleen Volume Dynamics and Survival Outcomes in HCC Patients Undergoing Immune Checkpoint Inhibitors: A Retrospective Analysis
Fu X, Jiang S, Li Y, Guo Y, Gong B, Lou J, Li Y, Wang S, Sun Y, Ren Y, Chen Q, Yang L
Journal of Hepatocellular Carcinoma 2025, 12:1069-1082
Published Date: 30 May 2025
Primary Prophylaxis for High-Risk Varices in Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombus Delayed Hepatic Decompensation: A Retrospective, Propensity Score Matching Study
Chen YJ, Hou MC, Yang TC, Lee PC, Lu HS, Huang HC, Huang YH, Luo JC
Journal of Hepatocellular Carcinoma 2025, 12:1057-1067
Published Date: 28 May 2025
Adjuvant Lenvatinib for High-Risk CNLC IIb/IIIa Hepatocellular Carcinoma After Curative Hepatectomy: A Prospective Exploratory Study
Sun HC, Huang ZY, Wen T, Liu L, Zhu XD, Zhang E, Li C, Zhang X, Wang J, Fan J, Zhou J
Journal of Hepatocellular Carcinoma 2025, 12:1043-1056
Published Date: 22 May 2025
Transarterial Chemoembolization, Molecular Targeted Treatments, and Programmed Death-(Ligand)1 Inhibitors, for Hepatocellular Carcinoma with Lung Metastasis: A Retrospective Cohort Study
Lu J, Chen X, Liu Y, Ding Y, Li B, Yang J, Peng W, Yang X
Journal of Hepatocellular Carcinoma 2025, 12:1031-1041
Published Date: 23 May 2025
Combination of Hepatic Arterial Infusion Chemotherapy with Tyrosine Kinase Inhibitor Provides Better Survival in Advanced Hepatocellular Carcinoma Patients
Liu CW, Lin PT, Teng W, Chen WT, Su CW, Hsieh YC, Lin CC, Lin CY, Lin SM
Journal of Hepatocellular Carcinoma 2025, 12:1017-1029
Published Date: 21 May 2025
Radiomics of Dynamic Contrast-Enhanced MRI for Predicting Radiation-Induced Hepatic Toxicity After Intensity Modulated Radiotherapy for Hepatocellular Carcinoma: A Machine Learning Predictive Model Based on the SHAP Methodology
Liu F, Chen L, Wu Q, Li L, Li J, Su T, Li J, Liang S, Qing L
Journal of Hepatocellular Carcinoma 2025, 12:999-1015
Published Date: 17 May 2025
MRI Radiomics to Predict Early Treatment Response to TACE Combined with Lenvatinib Plus a PD-1 Inhibitor for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
Lu D, Zhou L, Zuo Z, Zhang Z, Zheng X, Weng J, Yu Z, Ji J, Xia J
Journal of Hepatocellular Carcinoma 2025, 12:985-998
Published Date: 16 May 2025
Atezolizumab Plus Bevacizumab Combined with or without Transarterial Chemoembolization in the Treatment of Advanced Hepatocellular Carcinoma: A Single-Center Retrospective Study
Li J, Bai Y, Xiong F, Liu X, Hu J, Zhang G, Liu J, Wu S, Zheng C, Kan X
Journal of Hepatocellular Carcinoma 2025, 12:973-984
Published Date: 15 May 2025
The Real-World Prevalence of Esophagogastric Varices, Bleeding, Emergency Room Visits, and Hospitalization Among Patients with Advanced Hepatocellular Carcinoma in the United States: A Retrospective Cohort Study
Parikh ND, Park NJ, Locker M, Chopra I, Yeaw J, Yu S
Journal of Hepatocellular Carcinoma 2025, 12:961-972
Published Date: 15 May 2025
Can Intra-Operative Ablation-Specific Features Based on Ultrasound Fusion Imaging be Used to Predict Early Recurrence of Hepatocellular Carcinoma After Microwave Ablation: A Proof-of-Concept Study
Kang H, Liu Z, Huang B, Liang S, Yang K, Liu H, Lu M, Yan R, Chen X, Xu E
Journal of Hepatocellular Carcinoma 2025, 12:949-960
Published Date: 12 May 2025
Machine Learning Radiomics for Predicting Response to MR-Guided Radiotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter Cohort Study
Su K, Liu X, Zeng YC, Xu J, Li H, Wang H, Du S, Wang H, Yue J, Yin Y, Li Z
Journal of Hepatocellular Carcinoma 2025, 12:933-947
Published Date: 9 May 2025
Decoding ARF4 and EIF5B-Based Prognostic Signatures and Immune Landscape Following Insufficient Radiofrequency Ablation in Hepatocellular Carcinoma: Through Multi-Omics and Experimental Validation
Zhang Y, Lu Y, Zheng S, Luo W, Tan M, Luo B
Journal of Hepatocellular Carcinoma 2025, 12:909-931
Published Date: 9 May 2025
NRF1-Induced lncRNA DDX11-AS1 Contributes to the Progression of Hepatocellular Carcinoma via Activating CA9 Expression and the MEK/ERK Pathway
Li Y, Shi M, Bie B, Tian H, Li J, Li Z, Sun J
Journal of Hepatocellular Carcinoma 2025, 12:891-908
Published Date: 7 May 2025
Effectiveness of Minimally Invasive Hepatectomy in Patients with Early or Intermediate-Stage Hepatocellular Carcinoma: A Multi-Institutional Cohort Study in an Asian Population
Chen HK, Chang KC, Shao SC, Soong RS, Chen YC, Wu CF, Wu TH, Chou TS, Chan SC, Lai ECC
Journal of Hepatocellular Carcinoma 2025, 12:879-890
Published Date: 7 May 2025
Post-TACE ALBI-Score Trajectory in Intermediate and Advanced Hepatocellular Carcinoma: Prognostic Implications and Influencing Factors Analysis
Li J, Feng T, Cui C, Wang H, Su T, Jin L, Zhao X, Xiao W
Journal of Hepatocellular Carcinoma 2025, 12:865-878
Published Date: 5 May 2025
Prognostic Significance of Elevated Platelet Count (>200 x 10^9 per L) in BCLC Stages B and C of Hepatocellular Carcinoma: A Retrospective Multicenter Analysis
Munker S, Rodriguez I, Bernhart K, Ben Khaled N, Findik M, Siegmund LK, Ye L, Reiter FP, Roessler D, Nasseh D, Balcar L, Pomej K, Scheiner B, Weiss C, Pinter M, Seidensticker M, Mayerle J, Philipp AB, De Toni EN
Journal of Hepatocellular Carcinoma 2025, 12:855-864
Published Date: 5 May 2025
The Synergistic Mechanisms and Prospects of Transarterial Chemoembolization Combined with Immunotherapy for Hepatocellular Carcinoma
Chen QF, Chen S, Zhao M
Journal of Hepatocellular Carcinoma 2025, 12:841-854
Published Date: 30 April 2025
Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma: A Three-Dimensional Visualization Perspective
Tan Y, Li PP, Liu H, Zhu JY, Wu QS
Journal of Hepatocellular Carcinoma 2025, 12:837-840
Published Date: 28 April 2025

The Impact of Microwave Ablation on Recurrence and Metastasis of Hepatocellular Carcinoma: Insights From Animal Studies and Cytokine Profiling
Wang Y, Tan H, Wen C, Chen S, Zheng G, Qi H, Xie L, Shen L, Cao F, Fan W
Journal of Hepatocellular Carcinoma 2025, 12:825-835
Published Date: 26 April 2025
A Novel Prognostic Signature Integrating Immune and Glycolytic Pathways for Enhanced Prognosis and Immunotherapy Prediction in Hepatocellular Carcinoma
Zhang Z, Zhao H, Wang P, Geng X, Yin M, Liu Y, Zhang S, Liang Y, Ji J, Zheng G
Journal of Hepatocellular Carcinoma 2025, 12:805-823
Published Date: 18 April 2025
Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Real-World Experience From a US Community Oncology Network
Cosgrove D, Tan R, Osterland AJ, Hernandez S, Ogale S, Mahrus S, Murphy J, Wilson T, Patton G, Loaiza-Bonilla A, Singal AG
Journal of Hepatocellular Carcinoma 2025, 12:791-804
Published Date: 18 April 2025
Optimizing Treatment Selection for Early Hepatocellular Carcinoma Based on Tumor Biology, Liver Function, and Patient Status
Li X, Xu Y, Ou Y, Li H, Xu W
Journal of Hepatocellular Carcinoma 2025, 12:777-790
Published Date: 16 April 2025
A Novel Nomogram Model for Predicting the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection
Wu Y, Wang M, Zhang Z, Chen G, Zhang B
Journal of Hepatocellular Carcinoma 2025, 12:765-775
Published Date: 16 April 2025
Prognostic Analysis of Elderly Patients with Hepatocellular Carcinoma: an Exploration and Machine Learning Model Prediction Based on Age Stratification and Surgical Approach
Cai C, Zhu H, Li B, Tang C, Ren Y, Guo Y, Li J, Wang L, Li D, Li D
Journal of Hepatocellular Carcinoma 2025, 12:747-764
Published Date: 14 April 2025
Serum Osteopontin Enhances Hepatocellular Carcinoma Diagnosis and Predicts Anti-PD-L1 Immunotherapy Benefit
Wu M, Zou F, He S, Pi Y, Song Y, Chen S, Li L
Journal of Hepatocellular Carcinoma 2025, 12:729-745
Published Date: 13 April 2025
Preoperative Prediction of Macrotrabecular-Massive Hepatocellular Carcinoma Using Machine Learning-Based Ultrasomics
Li Y, Duan S, Ren S, Li D, Ma Y, Bu D, Liu Y, Li X, Cai X, Zhang L
Journal of Hepatocellular Carcinoma 2025, 12:715-727
Published Date: 12 April 2025
Rare Gingival Metastasis Occurring After Conversion Therapy Followed by Resection of Initially Unresectable Hepatocellular Carcinoma: A Case Report
Zhan J, Huang H, Zhan T, Liu X, Cheng Q
Journal of Hepatocellular Carcinoma 2025, 12:705-713
Published Date: 9 April 2025
Identification of FDFT1 and PGRMC1 as New Biomarkers in Nonalcoholic Steatohepatitis (NASH)-Related Hepatocellular Carcinoma by Deep Learning
Liu Q, Yang Y, Wang Y, Wei S, Yang L, Liu T, Yu Z, Feng Y, Yao P, Zhu Q
Journal of Hepatocellular Carcinoma 2025, 12:685-704
Published Date: 5 April 2025
ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab
Stefanini B, Fulgenzi CAM, Scheiner B, Korolewicz J, Cheon J, Nishida N, Ang C, Marron TU, Wu YL, Saeed A, Wietharn B, Rimassa L, Pirozzi A, Cammarota A, Pressiani T, Pinter M, Balcar L, Huang YH, Mehan A, Phen S, Vivaldi C, Salani F, Masi G, Bettinger D, Vogel A, Schönlein M, von Felden J, Schulze K, Wege H, Samson A, Galle PR, Kudo M, Manfredi GF, Celsa C, Awosika N, Cortellini A, Singal AG, Sharma R, Chon HJ, Tovoli F, Piscaglia F, Pinato DJ, D’Alessio A
Journal of Hepatocellular Carcinoma 2025, 12:671-683
Published Date: 4 April 2025
Machine Learning-Based Model Used for Predicting the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
Wu T, Yan J, Xiong F, Liu X, Zhou Y, Ji X, Meng P, Jiang Y, Hou Y
Journal of Hepatocellular Carcinoma 2025, 12:659-670
Published Date: 3 April 2025

Access to Medical Research is a Basic Human Right: A Roadmap to Research Integration Into a Practical Hepatocellular Carcinoma Treatment Allocation Algorithm (HCC-TAA)
Kaseb AO
Journal of Hepatocellular Carcinoma 2025, 12:649-657
Published Date: 28 March 2025
The Expression of Ferroptosis-Related Genes in Hepatocellular Carcinoma and Their Relationships With Prognosis
Li H, Hu X, Wang L, Gu X, Chen S, Tang Y, Chen Y, Chen J, Yuan Z, Wang Y
Journal of Hepatocellular Carcinoma 2025, 12:629-648
Published Date: 20 March 2025
Prediction Model of Survival in Unresectable HCC with Central Bile Duct Invasion Receiving TACE After Biliary Drainage: TEMP Score
Fan W, Zheng X, Zhang W, Zhu B, Wu Y, Xue M, Tang R, Huang Z, Qiao L, Lu M, Wu J, Tang Y, Chen J, Huang S, Bai M, Li J
Journal of Hepatocellular Carcinoma 2025, 12:615-628
Published Date: 20 March 2025
Study on the Mechanism of QRICH1 Mediating PRMT1 to Regulate the Arginine Methylation Modification of cGAS to Promote Arsenics-Induced Pyroptosis in Hepatocellular Carcinoma Cells
Zhang J, Tian T, Tian S, Yao J, Zhang Y, Xie R, Yang T, Han B
Journal of Hepatocellular Carcinoma 2025, 12:597-614
Published Date: 19 March 2025
A Chemotherapy Response-Related Gene Signature and DNAJC8 as Key Mediators of Hepatocellular Carcinoma Progression and Drug Resistance
Ye Y, Zeng Y, Huang S, Zhu C, Wang Q
Journal of Hepatocellular Carcinoma 2025, 12:579-595
Published Date: 20 March 2025
Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study
Chen X, Wu X, Peng W, Liu L, Liu X, Wan X, Xu H, Zheng Y, Zhao H, Mao Y, Lu X, Sang X, Chang X, Zhou K, Pan J, Guan M, Hu D, Tan H, Zhang Y, Du S
Journal of Hepatocellular Carcinoma 2025, 12:561-577
Published Date: 19 March 2025
Radiation Segmentectomy or Ablative External Beam Radiation Therapy as Initial Treatment for Solitary Hepatocellular Carcinoma: A Multicenter Experience
De la Garza-Ramos C, Montazeri SA, LeGout JD, Lewis AR, Frey GT, Paz-Fumagalli R, Hallemeier CL, Rutenberg MS, Ashman JB, Toskich BB
Journal of Hepatocellular Carcinoma 2025, 12:553-559
Published Date: 13 March 2025
Lasso-Based Nomogram for Predicting Early Recurrence Following Radical Resection in Hepatocellular Carcinoma
Zheng G, Zheng M, Hu P, Zhu Y, Zhang W, Zhang F
Journal of Hepatocellular Carcinoma 2025, 12:539-552
Published Date: 12 March 2025